The researchers’ objective was to study changes in prescriptions for opioid analgesics and buprenorphine for opioid use disorder among both new and existing patients during the COVID-19 pandemic.
The researchers investigated whether higher cumulative pain intensity is associated with an excess mortality risk in patients with psoriatic arthritis.
Analyses demonstrated improvement in key treatment outcomes vs placebo associated with baricitinib for the treatment of atopic dermatitis.
A study shows 7.8% of patients with psoriasis who were treated with methotrexate developed nonmelanoma skin cancer.
The safety, tolerability, and efficacy of sofpironium bromide gel for the treatment of primary axillary hyperhidrosis was evaluated.
Researchers at the AAD vmx 2021 describe the efficacy of ruxolitinib cream for atopic dermatitis based on baseline clinical characteristics using data from 2 studies.
Researchers detail case reports of 20 patients and examine a potential association between a treatment for facial eczema and conjunctivitis.
The researchers evaluated the various impacts of the concurrent COVID-19 and opioid epidemics, taking into consideration the severely restricted access to chronic pain management.
The researchers’ goal was to identify variables linked to poor pediatric patient-reported postsurgical outcomes.
Study uses SD-OCT imaging to evaluate the change to the corneal epithelium.
